-transparent.png){kind=logo}
OBJECTIVE To determine whether depressed patients demonstrate hypothalamic-pituitary-adrenal (HPA) axis activation during the late afternoon and evening, a time when the HPA axis is usually quiescent in normal subjects. METHODS We administered metyrapone, an 11-beta-hydroxylase inhibitor of cortisol synthesis, to normal controls and depressed patients between 4 and 10 PM. Metyrapone blockade of cortisol secretion would amplify any HPA axis secretion. RESULTS In 10 normal control subjects, administration of metyrapone lowered plasma cortisol levels to a mean of 36 nmol/L. No rebound corticotropin or beta-endorphin secretion was seen in these normal controls between 4 and 10 PM, supporting the existence of a period of minimal endogenous corticotropin releasing factor drive. Compared with a group of placebo-treated depressed patients (n = 10), metyrapone-treated depressed subjects (n = 17) had significantly decreased plasma cortisol concentrations. However, in contrast to normal controls treated with metyrapone, metyrapone-treated depressed patients demonstrated rebound corticotroph secretion, particularly between 7:30 and 10 PM (P = .036 for patients vs normal controls for beta-endorphin secretion from 4:30 to 10 PM). CONCLUSIONS These data support the hypothesis of increased corticotropin releasing factor drive in the evening in depressed subjects and are in agreement with the longstanding observation of "early escape" from dexamethasone suppression between 4 and 11 PM in depressed patients.
E A Young, and
R F Haskett, and
L Grunhaus, and
A Pande, and
V M Weinberg, and
S J Watson, and
H Akil
December 1982,
Journal of affective disorders,
E A Young, and
R F Haskett, and
L Grunhaus, and
A Pande, and
V M Weinberg, and
S J Watson, and
H Akil
December 1997,
Psychiatry research,
E A Young, and
R F Haskett, and
L Grunhaus, and
A Pande, and
V M Weinberg, and
S J Watson, and
H Akil
January 2001,
Journal of psychiatric research,
E A Young, and
R F Haskett, and
L Grunhaus, and
A Pande, and
V M Weinberg, and
S J Watson, and
H Akil
September 1994,
Endocrinology,
E A Young, and
R F Haskett, and
L Grunhaus, and
A Pande, and
V M Weinberg, and
S J Watson, and
H Akil
April 2009,
The Journal of clinical endocrinology and metabolism,
E A Young, and
R F Haskett, and
L Grunhaus, and
A Pande, and
V M Weinberg, and
S J Watson, and
H Akil
August 1994,
Respiratory medicine,
E A Young, and
R F Haskett, and
L Grunhaus, and
A Pande, and
V M Weinberg, and
S J Watson, and
H Akil
November 1983,
Clinics in endocrinology and metabolism,
E A Young, and
R F Haskett, and
L Grunhaus, and
A Pande, and
V M Weinberg, and
S J Watson, and
H Akil
January 1992,
Brain research,
E A Young, and
R F Haskett, and
L Grunhaus, and
A Pande, and
V M Weinberg, and
S J Watson, and
H Akil
November 2000,
American journal of obstetrics and gynecology,
E A Young, and
R F Haskett, and
L Grunhaus, and
A Pande, and
V M Weinberg, and
S J Watson, and
H Akil
February 1989,
Endocrine reviews,
